Epstein-Barr virus-positive mucocutaneous ulcer in a patient with polycythemia vera treated with oral hydroxyurea

J Dermatol. 2018 Apr;45(4):e82-e83. doi: 10.1111/1346-8138.14127. Epub 2017 Nov 15.

Authors

Toshihisa Hamada¹, Mariko Kawata¹, Yoshinobu Maeda², Tadashi Yoshino³, Tomoko Miyake¹, Shin Morizane¹, Yoji Hirai¹, Keiji Iwatsuki¹

Affiliations

¹ Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
² Department of Hematology, Oncology, Allergy and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
³ Department of Pathology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.

PMID: 29139148
DOI: 10.1111/1346-8138.14127

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Oral
Aged
Antineoplastic Agents / adverse effects*
Antineoplastic Agents / therapeutic use*
Antineoplastic Combined Chemotherapy Protocols
Epstein-Barr Virus Infections / chemically induced*
Epstein-Barr Virus Infections / drug therapy
Epstein-Barr Virus Infections / radiotherapy
Fatal Outcome
Herpesvirus 4, Human
Humans
Hydroxyurea / adverse effects*
Hydroxyurea / therapeutic use*
Lymphoproliferative Disorders / chemically induced*
Lymphoproliferative Disorders / drug therapy
Lymphoproliferative Disorders / radiotherapy
Male
Polycythemia Vera / drug therapy*
Ulcer / chemically induced

Substances

Antineoplastic Agents
Hydroxyurea